Table 3 Change in composition and functional activity of in vivo cultured EC cells after pretreatment with hybrid nanocomplexes

Concentration of cells with corresponding phenotype, %

CD44^high

0.09 ± 0.01^*

0.02 ± 0.001^{*, **}

0.17 ± 0.03

CD44⁺CD24^–

0.75 ± 0.05^*

0.40 ± 0.02^{*, **,}

3.78 ± 0.51

CD44⁺CD24⁺

2.75 ± 0.28

9.77 ± 0.62^{*, **}

2.89 ± 0.22

CD44^–CD24⁺

6.18 ± 0.32

7.85 ± 0.44^*

5.33 ± 0.64

Sca-1⁺

81.82 ± 5.28

83.77 ± 5.73

90.32 ± 5.33

CD117⁺

5.04 ± 0.32

10.47 ± 0.83^*,**

7.81 ± 0.83

0.018

0.002

0.02

14.53 ± 0.72^*

9.06 ± 0.25^*,**

35.80 ± 2.27

59.41 ± 3.45

74.70 ± 4.38^**

–